107 related articles for article (PubMed ID: 36339661)
1. The SARS-CoV-2 Infection Among Students in the University of Porto: A Cross-Sectional Study.
Meireles P; Costa JP; Novais MJ; Miranda D; Lopes MM; Severo M; Barros H
Int J Public Health; 2022; 67():1604548. PubMed ID: 36339661
[No Abstract] [Full Text] [Related]
2. Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.
Meireles P; Amaro J; Pinto da Costa J; Lopes MM; Varandas T; Norton P; Guimarães JT; Severo M; Barros H
Occup Environ Med; 2021 Sep; 78(9):648-653. PubMed ID: 34193594
[TBL] [Abstract][Full Text] [Related]
3. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of seroprevalence in a cohort of university students of Rome (Italy) between September 2020 and July 2021.
Ulivieri A; Morgante A; Magi F; Salehi LB; Lavra L
Epidemiol Prev; 2022; 46(5-6):367-375. PubMed ID: 36628641
[TBL] [Abstract][Full Text] [Related]
5. Measuring the clustering effect of the SARS-CoV-2 transmission in a school population: a cross-sectional study in a high incidence region.
Severo M; Meireles P; Ribeiro AI; Morais V; Barros H
Sci Rep; 2023 Sep; 13(1):16300. PubMed ID: 37770455
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon.
Essomba RG; Bayibeki AN; Lissom A; Ateba PT; Seni N; Fouda CAN; Mbitock SBD; Ebonda ND; Afana SD; Akame S; Tembu AA; Ngamaleu MR; Bimai BCB; Kabo O; Nguwoh PS; Ngounouh CT; Meka MCJ; Kengne M; Likeng JN; Kimessoukie EO; Nkoum BA; Assoumou MCO; Fokam J; Yap Boum II; Ambomo MS; Chadou MJP
Influenza Other Respir Viruses; 2023 Nov; 17(11):e13222. PubMed ID: 37964992
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.
Javed W; Abidi SHB; Baqar JB
BMC Infect Dis; 2022 May; 22(1):481. PubMed ID: 35596145
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.
Lachassinne E; de Pontual L; Caseris M; Lorrot M; Guilluy C; Naud A; Dommergues MA; Pinquier D; Wannepain E; Hausherr E; Jung C; Gajdos V; Cohen R; Zahar JR; Brichler S; Basmaci R; Boelle PY; Bloch-Queyrat C; Aupiais C;
Lancet Child Adolesc Health; 2021 Apr; 5(4):256-264. PubMed ID: 33571450
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of SARS -CoV-2 IgG/IgM antibodies among patients in Zakho City, Kurdistan, Iraq.
Saeed AY; Assafi MS; Othman HE; Shukri HM
J Infect Dev Ctries; 2022 Jul; 16(7):1126-1130. PubMed ID: 35905016
[TBL] [Abstract][Full Text] [Related]
13. Study of seroprevalence of SARS-CoV-2 in Kazakhstan.
Kulimbet M; Saliev T; Alimbekova G; Ospanova D; Tobzhanova K; Tanabayeva D; Zhussupov B; Fakhradiyev I
Epidemiol Infect; 2023 Jul; 151():e116. PubMed ID: 37409465
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in the Mozambican Population: A Cross-Sectional Serologic Study in 3 Cities, July-August 2020.
Arnaldo P; Mabunda N; Young PW; Tran T; Sitoe N; Chelene I; Nhanombe A; Ismael N; Júnior A; Cubula B; Inlamea OF; Gudo E; Jani IV
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S285-S293. PubMed ID: 35748663
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis.
Hajissa K; Islam MA; Hassan SA; Zaidah AR; Ismail N; Mohamed Z
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742506
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities.
Malagón-Rojas JN; Mercado-Reyes M; Toloza-Pérez YG; Parra Barrera EL; Palma M; Muñoz E; López R; Almentero J; Rubio VV; Ibáñez E; Téllez E; Delgado-Murcia LG; Jimenez CP; Viasus-Pérez D; Galindo M; Lagos L;
Occup Environ Med; 2022 Jun; 79(6):388-395. PubMed ID: 34740981
[TBL] [Abstract][Full Text] [Related]
18. Population seroprevalence of SARS-CoV-2 antibodies in Anambra State, South-East, Nigeria.
Okpala OV; Dim CC; Ugwu CI; Onyemaechi S; Uchebo O; Chukwulobelu U; Emembolu C; Okoye B; Igboekwu C; Okoye UB; Dike NC; Odumegwu AO; Ideh C; Okoye NC; Okpala VC; Okoye PI; Enike MC; Onyedikachi O
Int J Infect Dis; 2021 Sep; 110():171-178. PubMed ID: 34293489
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.
Darvishian M; Sharafkhah M; Mohammadi Z; Sadeghniiat-Haghighi K; Abdollahi A; Jafary M; Talaschian M; Tabarsi P; Baghai P; Mardani M; Shayanrad A; Shafighian F; Markarian M; Roozafzai F; Zamani M; Alvand S; Hariri S; Sadeghi A; Poustchi H; Malekzadeh R
Front Public Health; 2022; 10():832003. PubMed ID: 35400056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
